| Income Statement |
| Total Revenue | 25.56M |
|
| Revenues (USD) | 25.56M |
| Cost of Revenue | 4.21M |
| Gross Profit | 21.35M |
| Operating Expenses | 27.55M |
| Research and Development Expense | 3.29M |
| Selling, General and Administrative Expense | 24.26M |
| Operating Income | -6.20M |
| Interest Expense | 1.98M |
| Net Income | -7.79M |
| Net Income Common Stock | -7.79M |
| Net Income Common Stock (USD) | -7.79M |
| Consolidated Income | -7.79M |
| Earnings per Basic Share | -0.81 |
| Earnings per Basic Share (USD) | -0.81 |
| Earnings per Diluted Share | -0.81 |
| Earning Before Interest & Taxes (EBIT) | -5.82M |
| Earning Before Interest & Taxes (USD) | -5.82M |
| Weighted Average Shares | 9.66M |
| Weighted Average Shares Diluted | 9.66M |
| Balance Sheet |
| Cash and Equivalents | 25.57M |
| Cash and Equivalents (USD) | 25.57M |
| Trade and Non-Trade Receivables | 9.50M |
| Current Assets | 40.91M |
| Property, Plant & Equipment Net | 27.38M |
| Total Assets | 94.64M |
| Debt Current | 1.45M |
| Total Debt | 71.61M |
| Current Liabilities | 14.49M |
| Debt Non-Current | 70.16M |
| Total Liabilities | 85.51M |
| Accumulated Retained Earnings (Deficit) | -505.55M |
| Shareholders Equity | 9.13M |
| Shareholders Equity (USD) | 9.13M |
| Assets Non-Current | 53.73M |
| Total Debt (USD) | 71.61M |
| Deferred Revenue | 223.00K |
| Goodwill and Intangible Assets | 18.48M |
| Liabilities Non-Current | 71.02M |
| Trade and Non-Trade Payables | 3.65M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 1.42M |
| Net Cash Flow from Financing | 16.90M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 6.59M |
| Capital Expenditure | -144.00K |
| Issuance (Purchase) of Equity Shares | 17.57M |
| Issuance (Repayment) of Debt Securities | -33.00K |
| Net Cash Flow from Investing | -144.00K |
| Net Cash Flow from Operations | -10.17M |
| Share Based Compensation | 1.12M |